Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
Latest Information Update: 11 Feb 2022
At a glance
- Drugs Ivabradine (Primary)
- Indications Tachycardia
- Focus Therapeutic Use
- 28 Jun 2021 Status changed from suspended to discontinued.
- 04 Apr 2021 Status changed from recruiting to suspended as study funding terminated.
- 16 Dec 2019 Planned primary completion date changed from 30 Apr 2020 to 30 Apr 2021.